p53 has also been found to be an autoantigen in colorectal cancer and, in a meta-analysis considering 199 antigens, it was found to be an important auto-antibody for diagnostic purposes in combination with those against c-MYC, cyclin B1, p62, Koc, IMP1, and survivin [42]. Here, IGF2BP2 is linked to colorectal cancer.